Categories: Market Research

(2024-2033) Tissue Sectioning Market Size, Share, Trends, Industry Growth Analysis and Forecast | Thermo Fisher Scientific Inc., Danaher Corporation, Labcorp Drug Development

Tissue Sectioning Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size –
The tissue sectioning market size has grown strongly in recent years. It will grow from $0.69 billion in 2023 to $0.76 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to increasing prevalence of chronic diseases, growing aging population, rising investments in life sciences research, expanding biotechnology and pharmaceutical industries, government initiatives supporting research, rising demand for companion diagnostics, increasing awareness about early disease detection, growth in regenerative medicine.

The tissue sectioning market size is expected to see strong growth in the next few years. It will grow to $1.11 billion in 2028 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to demand for personalized medicine, growth in biobanks, investments in research and development, increasing healthcare expenditure, growing awareness about early disease detection, emergence of digital pathology, rising demand for biomarker discovery, growing biopharmaceutical industry, rising demand for point of care testing. Major trends in the forecast period include advancements in automation technology, integration of ai and machine learning, digital pathology integration, adoption of 3d tissue sectioning techniques, development of high throughput solutions, expansion of research applications, development of novel cutting techniques, advancements in imaging modalities, adoption of cryosectioning techniques.

Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/tissue-sectioning-global-market-report

Scope Of Tissue Sectioning Market
The Business Research Company’s reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Tissue Sectioning Market Overview

Market Drivers –

The rising surgical procedures are expected to propel the growth of the tissue sectioning market going forward. Surgical procedures are medical interventions involving instruments to diagnose, treat, or repair the body. The rise in surgical procedures is due to advancements in medical technology, demographic changes, and shifts in healthcare practices. Tissue sectioning aids surgical procedures by providing precise, thin tissue slices for histological analysis, enabling accurate diagnosis, treatment planning, and transplantation. For instance, in December 2023, according to the Australian Institute of Health and Welfare (AIHW), an Australia-based government agency for public health and welfare, in 2022–23, there were 735,500 patients admitted for surgery from public hospital elective surgery waiting lists, marking an 18% rise from 2021–22. Therefore, rising surgical procedures are driving the tissue sectioning market.

Market Trends –

Major companies operating in the tissue sectioning market are developing advanced technologies, such as next-generation spatial gene expression technology, to enhance tissue analysis and diagnostics. Next-generation spatial gene expression technology allows for the detailed mapping of gene activity within tissue sections, providing insights into the spatial organization of gene expression and tissue architecture. For instance, in March 2024, 10x Genomics, a US-based biotechnology company, launched Visium HD, a next-generation spatial gene expression technology that enables precise gene expression mapping in detailed anatomical structures. It is designed to provide high-resolution spatial gene expression data at single-cell scale resolution from formalin-fixed, paraffin-embedded (FFPE) tissue sections. This technology allows for comprehensively characterizing FFPE tissue sections by measuring whole transcriptome spatial gene expression at single-cell resolution.

The tissue sectioning market covered in this report is segmented –

1) By Product: Accessories And Consumables, Instruments, Services
2) By Technology: Automatic, Manual, Semi-Automatic
3) By Application: Diagnosis, Research
4) By End-User: Clinics, Diagnostic Laboratories, Hospitals, Research Centers

Get an inside scoop of the tissue sectioning market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample_request?id=16555&type=smp

Regional Insights –
North America was the largest region in the tissue sectioning market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tissue sectioning market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies –
Major companies operating in the tissue sectioning market are Thermo Fisher Scientific Inc., Danaher Corporation, Labcorp Drug Development, Agilent Technologies Inc., Leica Biosystems Nussloch GmbH, Abcam Limited, Sakura Finetek USA Inc., Ted Pella Inc., Santa Cruz Biotechnology Inc., Milestone Srl, Diapath S.p.A., Bio-Optica Milano S.p.A, MEDITE Medical GmbH, PathnSitu Biotechnologies Pvt Ltd, Tanner Scientific Inc., Boeckeler Instruments Inc., SLEE Medical GmbH, Amos Scientific PTY. LTD., LLS ROWIAK LaserLabSolutions GmbH, SM Scientific Instruments Pvt. Ltd., Bright Instrument Co. Ltd., RWD Life Science Co. Ltd., Hacker Instruments & Industries Inc.

Table of Contents

1. Executive Summary

2. Tissue Sectioning Market Characteristics

3. Tissue Sectioning Market Trends And Strategies

4. Tissue Sectioning Market – Macro Economic Scenario

5. Global Tissue Sectioning Market Size and Growth

…..

32. Global Tissue Sectioning Market Competitive Benchmarking

33. Global Tissue Sectioning Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Tissue Sectioning Market

35. Tissue Sectioning Market Future Outlook and Potential Analysis

36. Appendix